» Articles » PMID: 12898283

Significance of Aspergillus Fumigatus Isolation from Respiratory Specimens of Nongranulocytopenic Patients

Overview
Publisher Springer
Date 2003 Aug 5
PMID 12898283
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of this study was to determine the significance of isolation of Aspergillus fumigatus from cultures of respiratory specimens in nongranulocytopenic patients. The medical records of patients with respiratory specimens positive for Aspergillus fumigatus who were admitted to an adult pneumology ward were reviewed during a 2-year period. A total of 80 respiratory specimens from 76 patients yielded Aspergillus fumigatus. Forty-eight patients were colonized with Aspergillus fumigatus, whereas the 28 (37%) remaining patients had pulmonary aspergillosis, manifest as aspergilloma ( n=19 patients), chronic necrotizing pulmonary aspergillosis ( n=7 patients), and bronchial aspergillosis ( n=2 patients). The presence of typical hyphae in direct examination of bronchoscopic specimens was more likely to be found in infected than in colonized patients ( P=0.04). No immunological test was positive in colonized patients, whereas anti- Aspergillus antibodies were detected in 55% of infected patients ( P<0.001). Pulmonary tuberculosis was the most common underlying lung disease in patients with aspergilloma, but it was not found in any patient with chronic necrotizing pulmonary aspergillosis ( P=0.006). Anti- Aspergillus antibodies were more likely to be detected in patients with aspergilloma (78%) than in patients with chronic necrotizing pulmonary aspergillosis (14%) ( P=0.007). The analysis of predisposing factors, in conjunction with immunological tests and examination of bronchoscopic specimens, is helpful in distinguishing between colonization and infection with Aspergillus fumigatus, as well as for differentiating between aspergilloma and chronic necrotizing pulmonary aspergillosis.

Citing Articles

Chronic pulmonary aspergillosis: comprehensive insights into epidemiology, treatment, and unresolved challenges.

Tashiro M, Takazono T, Izumikawa K Ther Adv Infect Dis. 2024; 11:20499361241253751.

PMID: 38899061 PMC: 11186400. DOI: 10.1177/20499361241253751.


Chronic pulmonary aspergillosis - a guide for the general physician.

Carter C, Kahai R, Cunningham J, Kilduff J, Hough N, Baxter C Clin Med (Lond). 2024; 24(1):100019.

PMID: 38281665 PMC: 11024841. DOI: 10.1016/j.clinme.2024.100019.


The SSS revolution in fungal diagnostics: speed, simplicity and sensitivity.

Baker J, Denning D Br Med Bull. 2023; 147(1):62-78.

PMID: 37328942 PMC: 10502448. DOI: 10.1093/bmb/ldad011.


Prevalence of chronic pulmonary aspergillosis in fibrocavitary pulmonary tuberculosis patients.

Rajpurohit R, Wagh P, Heda M, Dubey G, Gujar P J Family Med Prim Care. 2023; 12(1):106-110.

PMID: 37025238 PMC: 10071912. DOI: 10.4103/jfmpc.jfmpc_846_22.


Validity of Platelia Aspergillus IgG and Aspergillus Precipitin Test To Distinguish Pulmonary Aspergillosis from Colonization.

Shinfuku K, Suzuki J, Takeda K, Kawashima M, Morio Y, Sasaki Y Microbiol Spectr. 2022; 11(1):e0343522.

PMID: 36475776 PMC: 9927562. DOI: 10.1128/spectrum.03435-22.


References
1.
Bodey G, Vartivarian S . Aspergillosis. Eur J Clin Microbiol Infect Dis. 1989; 8(5):413-37. DOI: 10.1007/BF01964057. View

2.
Sharma O, Chwogule R . Many faces of pulmonary aspergillosis. Eur Respir J. 1998; 12(3):705-15. DOI: 10.1183/09031936.98.12030705. View

3.
Horvath J, Dummer S . The use of respiratory-tract cultures in the diagnosis of invasive pulmonary aspergillosis. Am J Med. 1996; 100(2):171-8. DOI: 10.1016/s0002-9343(97)89455-7. View

4.
Perfect J, Cox G, Lee J, Kauffman C, de Repentigny L, Chapman S . The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis. Clin Infect Dis. 2001; 33(11):1824-33. DOI: 10.1086/323900. View

5.
Miller W . Aspergillosis: a disease with many faces. Semin Roentgenol. 1996; 31(1):52-66. DOI: 10.1016/s0037-198x(96)80040-x. View